Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome

Journal of Cardiology

Volumn 60, Issue 1, 2012, Pages 47-54

  Omiya, Toshihide ^a   Shimizu, Akihiko ^a   Ueyama, Takeshi ^a   Yoshiga, Yasuhiro ^a   Doi, Masahiro ^a   Hiratsuka, Atsushi ^a   Fukuda, Masakazu ^a   Yoshida, Masaaki ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brugada syndrome; Fast Fourier transform; Isoproterenol; Propranolol; Ventricular fibrillation

Indexed keywords

ISOPRENALINE; PROPRANOLOL;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOURIER TRANSFORMATION; HEART FUNCTION TEST; HEART VENTRICLE FIBRILLATION; HUMAN; MALE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; PROPRANOLOL; VENTRICULAR FIBRILLATION;

EID: 84864071967     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.02.001     Document Type: Article

References (26)

1. Brugada J., Brugada R., Brugada P. Right bundle-branch block and ST segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998, 97:457-460.
2. Wilde A.A., Antzelevitch C., Borggrefe M., Brugada J., Brugada R., Brugada P., Corrado D., Hauer R.N., Kass R.S., Nademanee K., Priori S.G., Towbin J.A. Proposed diagnostic criteria for the Brugada syndrome. Circulation 2002, 106:2514-2519. Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology.
3. Kasanuki H., Ohnishi S., Ohtuka M., Matsuda N., Nirei T., Isogai R., Shoda M., Toyoshima Y., Hosoda S. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997, 95:2277-2285.
4. Makimoto H., Nakagawa E., Takaki H., Yamada Y., Okamura H., Noda T., Satomi K., Suyama K., Aihara N., Kurita T., Kamakura S., Shimizu W. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010, 56:1576-1584.
5. Ikeda T., Abe A., Yusu S., Nakamura K., Ishiguro H., Mera H., Yotsukura M., Yoshino H. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol 2006, 17:602-607.
6. Wichter T., Matheja P., Eckardt L., Kies P., Schafers K., Schulze-Bahr E., Haverkamp W., Borggrefe M., Schober O., Breithardt G., Schäfers M. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002, 105:702-706.
7. Watanabe A., Kusano K.F., Morita H., Miura D., Sumida W., Hiramatsu S., Banba K., Nishii N., Nagase S., Nakamura K., Sakuragi S., Ohe T. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J 2006, 27:1579-1583.
8. Sánchez-Muñoz J.J., Rojo-Alvarez J.L., García-Alberola A., Everss E., Alonso-Atienza F., Ortiz M., Martínez-Sánchez J., Ramos-López J., Valdés-Chavarri M. Spectral analysis of intracardiac electrograms during induced and spontaneous ventricular fibrillation in humans. Europace 2009, 11:328-331.
9. Taneja T., Goldberger J., Parker M.A., Johnson D., Robinson N., Horvath G., Kadish A.H. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol 1997, 8:1209-1217.
10. Chorro F.J., Sánchez-Muñoz J.J., Sanchis J., Cortina J., Bataller M., Guerrero J., Espí J., Ruipérez J.A., López-Merino V. Modifications in the evolution of the dominant frequency in ventricular fibrillation induced by amiodarone, diltiazem, and flecainide. An experimental study. J Electrocardiol 1996, 29:319-326.
11. Clayton R.H., Murray A., Campbell R.W. Analysis of the body surface ECG measured in independent leads during ventricular fibrillation in humans. PACE 1995, 18:1876-1881.
12. Shimizu A., Ueyama T., Yoshiga M., Sawa A., Suzuki S., Sugi N., Matsuzaki M. Spectral analysis of atrial fibrillation cycle lengths: comparison between Fast Fourier transform analysis and autocorrelation function analysis using multipurpose physio-informatic analysis software. Circ J 2007, 71:242-251.
13. Sanders P., Berenfeld O., Hocini M., Jaïs P., Vaidyanathan R., Hsu L.F., Garrigue S., Takahashi Y., Rotter M., Sacher F., Scavée C., Ploutz-Snyder R., Jalife J., Haïssaguerre M. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005, 112:789-797.
14. Latcu G.D., Meste O., Duparc A., Mondoly P., Rollin A., Delay M., Maury P. Temporal and spectral analysis of ventricular fibrillation in humans. J Interv Card Electrophysiol 2011, 30:199-209.
15. Sugi N., Shimizu A., Ueyama T., Yoshiga Y., Sawa A., Suzuki S., Ohmiya T., Ohno M., Matsuzaki M. Electrophysiological characteristics of induced ventricular fibrillation in Brugada syndrome. Circ J 2007, 71(Suppl I):331.
16. + channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function. Circ J 2007, 71:57-62.
17. Shimizu A. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro). Circ J 2010, 74:2455-2463.
18. Sugi N., Shimizu A., Ueyama T., Yoshiga Y., Doi M., Ohmiya T., Ohno M., Yoshida M., Matsuzaki M. What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease. J Cardiol 2010, 56:35-43.
19. Mäkikallio T.H., Huikuri H.V., Myerburg R.J., Seppänen T., Kloosterman M., Interian A., Castellanos A., Mitrani R.D. Differences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation. Ann Med 2002, 34:130-135.
20. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., Priori S.G., Quinones M.A., Roden D.M., Silka M.J., Tracy C., et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e385-e484.
21. Taneja T., Goldberger J., Johnson D., Kadish A. Is all ventricular fibrillation the same? Influence of mode of induction on characteristics of ventricular fibrillation. J Cardiovasc Electrophysiol 2000, 11:1355-1363.
22. Jacobson J.T., Johnson D., Horvath G., Goldberger J., Kadish A. Effect of underlying heart disease on the frequency content of ventricular fibrillation in the dog heart. Pacing Clin Electrophysiol 2000, 23:243-252.
23. Di Maio R., Allen J.D., Navarro C., Darragh K., Anderson J.M., Adgey A.A. Changes in the frequency spectrum, the P-P interval, and the bispectral index during ventricular fibrillation are physiologic indicators of ventricular fibrillation duration. J Electrocardiol 2009, 42:527-533.
24. Carlisle E.J., Allen J.D., Kernohan W.G., Anderson J., Adgey A.A. Fourier analysis of ventricular fibrillation of varied aetiology. Eur Heart J 1990, 11:173-181.
25. Panfilov I., Lever N.A., Smaill B.H., Larsen P.D. Ventricular fibrillation frequency from implanted cardioverter defibrillator devices. Europace 2009, 11:1052-1056.
26. Yan G.X., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999, 100:1660-1666.